LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
44.07
+0.57 (1.31%)
May 8, 2025, 4:00 PM EDT - Market closed
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.40 billion as of May 8, 2025. Its market cap has decreased by -17.54% in one year.
Market Cap
2.40B
Enterprise Value
2.34B
1-Year Change
-17.54%
Ranking
Category
Stock Price
$44.07
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.40B, a decrease of -29.64%. That is a compound annual growth rate of -3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 2.37B | -5.68% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.94B |
| Johnson & Johnson | 376.02B |
| UnitedHealth Group | 354.33B |
| AbbVie | 328.99B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 234.95B |
| AstraZeneca | 217.30B |
| Novartis AG | 215.89B |